Why The Roche Holding (SWX:ROG) Narrative Is Shifting On Mixed Pipeline Signals And Valuation [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Roche Holding's updated fair value estimate has shifted from CHF 358.45 to CHF 363.47, a modest move that keeps the focus on how the story is evolving rather than on a sweeping reset. That small change sits alongside a split in recent analyst views, with some pointing to potential upside and others holding back due to pipeline timing and trial questions. As you read on, you will see how these differing opinions shape the narrative and what to watch to stay on top of it. Stay updated as the Fair Value for Roche Holding shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Roche Holding. What Wall Street Has Been Saying ?? Bullish Takeaways Barclays upgraded Roche to Overweight from Equal Weight with a CHF 390 price target, highlighting what it calls an attractive setup for 2026 clinical catalysts and an undemanding valuation. Goldman Sachs upgraded Roche to Neutral on what it describes as improved growth pot
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE marketsPR Newswire
- Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE marketsPR Newswire
- Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development [Yahoo! Finance]Yahoo! Finance
- How AI Is Transforming Patient Health At Genentech [Forbes]Forbes
- Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson's and Alzheimer's Disease at AD/PD™ 2026 [Yahoo! Finance]Yahoo! Finance